Exin Therapeutics
PrivateLast Round
Seed
Feb 10, 2026
Total Funding Raised
$3.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exin Therapeutics is a biotechnology company that develops an AI-driven drug discovery platform and genetic therapies to target neurological and neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exin Therapeutics Comparables
Compare Exin Therapeutics with similar companies based on industry and business-model similarity.
Exin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 10, 2026 | ||||
| Seed | May 20, 2025 | ||||
| Accelerator | Jan 1, 2025 |
Key People
Founding team and executive leadership
Exin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator, Seed |
| Tekedia Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
Raised $2.16M in a seed funding round.
- Jan 1, 2025
$500K raised from Y Combinator.
Exin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exin Therapeutics's valuation, stock price, and market status.